Home » Topics » Regulatory

Regulatory
RSS

European approval granted for Ketek, Aventis' first-in-class antibiotic

Aug. 21, 2001

FDA approves Natrecor for treatment of congestive heart failure

Aug. 14, 2001

Roche receives first approval for PEGASYS

Aug. 10, 2001

BVdU reported to be useful for inhibiting the growth of hyperproliferative cells

Aug. 9, 2001

Replagal receives European approval for Fabry's disease

Aug. 9, 2001

New intraocular pressure-lowering agent introduced to Japanese market

July 31, 2001

Genotropin approved in U.S. for growth failure in children born SGA

July 31, 2001

Dutch approval of Remeron SolTab

July 31, 2001

Expanded use of Visudyne approved by Canadian authorities

July 30, 2001

OxyContin labeling changes reflect new FDA warnings

July 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...